Listed

Nephros Inc: Form 10-K for the period ended Dec 31, 2017

Filed with the SEC on Feb 26, 2018 and accepted by EDGAR at Feb 26, 2018, 07:31 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Gross profit12 months2017-01-01 to 2017-12-31$2.3mus-gaap:GrossProfit
Selling, general and administrative12 months2017-01-01 to 2017-12-31$3.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2017-01-01 to 2017-12-31−$2.2mus-gaap:OperatingIncomeLoss
Interest expense12 months2017-01-01 to 2017-12-31$302.0kus-gaap:InterestExpense
Income tax12 months2017-01-01 to 2017-12-31−$1.8mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2017-01-01 to 2017-12-31−$809.0kus-gaap:NetIncomeLoss
Diluted EPS12 months2017-01-01 to 2017-12-31−$0.02us-gaap:EarningsPerShareBasicAndDiluted
Cash and equivalentsAt period end2017-12-31$2.2mus-gaap:Cash
Current assetsAt period end2017-12-31$3.8mus-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$5.0mus-gaap:Assets
Current liabilitiesAt period end2017-12-31$1.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-12-31$3.0mus-gaap:Liabilities
Shareholders' equityAt period end2017-12-31$1.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-18-002569. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.